Fidasimtamab, CAS 2377419-89-9

Product Description: Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Shijie Jin, et al. Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduct Target Ther. 2022 Feb 7;7(1):39. 

CAS Number: 2377419-89-9

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: EGFR;PD-1/PD-L1

• SKU: MEXHY-P99618-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99618-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated